# \[e-drug\] ADRs and cox 2 inhibitors (cont)

**URL:** <https://talk.edrugplus.org/t/e-drug-adrs-and-cox-2-inhibitors-cont/9015>\
**Category:** e-drug\
**Created:** [August 27, 2000, 11:05am UTC](https://talk.edrugplus.org/t/e-drug-adrs-and-cox-2-inhibitors-cont/9015 "2000-08-27T11:05:59Z")\
**Posts on this page:** 1\
**Page:** 1

<div class="post-metadata">

**Author:** ![Bradley\_Parsons](https://avatars.discourse-cdn.com/v4/letter/b/fbc32d/32.png) [@Bradley\_Parsons](https://talk.edrugplus.org/u/Bradley_Parsons)\
**Post date:** [August 27, 2000, 11:05am UTC](https://talk.edrugplus.org/t/e-drug-adrs-and-cox-2-inhibitors-cont/9015/1 "2000-08-27T11:05:59Z")

</div>

E-drug: ADRs and cox 2 inhibitors (cont)  
---------------------------------------------  
Dear Jody

I refer to the Canadian Adverse Drug Reaction Newsletter Vol 10  
Number 2 April 2000. The newsletter lists 6 cases of fatalities  
linked to celecoxib (including subarachnoid hemorrhage, intracranial  
hemorrhage). This should obviously be looked at in proportion to the  
huge number of patients who have taken these new NSAIDs. Like all  
drugs, the COX-2 inhibitors will have untoward effects, although  
fatal cases of bleeding are of concern.

Kind regards  
Bradley Parsons (B.Pharm)  
"Bradley Parsons" \<bparsons@adcock.co.za\>  
[Please include your affiliation and physical address. BS]  
--  
Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'.  
Mail administrative requests to `majordomo@usa.healthnet.org'.  
For additional assistance, send mail to: `owner-e-drug@usa.healthnet.org'.
